Last reviewed: June 7, 2026
Last updated: June 7, 2026
Written by:
Jay Hastings,
CEO of PlexusDx
Jay Hastings is the CEO of PlexusDx, a precision health company focused on genetic testing, blood biomarker insights, and personalized wellness recommendations. He has more than 20 years of experience across healthcare innovation, genomics, laboratory operations, healthcare investing, and strategic finance.
Medically reviewed by:
Jayden Lee, PharmD, EMBA
Jayden Lee, PharmD, EMBA, is the PlexusDx Medical Science Liaison with a PharmD and MBA specializing in pharmacogenomics and clinical product development, with a proven ability to bridge the gap between genomic research and practical patient outcomes. Dr. Lee has more than 10 years of professional experience in clinical pharmacy, academia, and research.
This article is part of the PlexusDx Education Hub — science-backed guidance on GLP-1 medications, metabolic health, and precision weight management.
Semaglutide has become one of the most researched GLP-1 receptor agonists for weight management, with clinical trials demonstrating sustained weight loss across thousands of participants. However, the question "How much weight will I lose?" has no single answer—your results depend on multiple biological and behavioral factors that interact in ways unique to your body. Understanding what the science shows, and what influences your personal outcome, helps set realistic expectations before starting therapy.
Clinical Trial Data: What Semaglutide Weight Loss Studies Show
The STEP trials, which tested semaglutide in people with obesity and overweight, documented weight loss ranging from 5% to 22% depending on the dose and population studied. At the highest tested dose of 2.4 mg weekly, participants lost an average of 15% of their baseline body weight over 68 weeks—roughly 35 pounds for someone starting at 230 pounds. These results were significantly greater than the placebo group, which lost only 2.4% on average, highlighting that semaglutide's effect is real and measurable.
Weight loss typically accelerates during the first 16 weeks as the body adjusts to the medication and appetite signaling shifts downward. Many patients experience a plateau around weeks 20 to 30, after which gradual continued loss may occur through week 52 and beyond. The studies also showed that people who maintained lifestyle changes—regular physical activity and consistent dietary choices—achieved better outcomes than those who relied on medication alone.
Why Your Results May Differ: Genetic and Metabolic Factors
Your genetics influence how effectively semaglutide works by affecting GLP-1 receptor sensitivity, glucose regulation, and appetite control pathways. The Precision Peptide Genetic Test from PlexusDx analyzes variants including GLP1R rs6923761, which impacts receptor function, and GIPR rs1800437, which affects a related satiety pathway. These genetic markers help explain why one person loses 25 pounds while another on the same dose loses 10 pounds—it's not effort or discipline, it's how your genes express appetite-suppressing receptors.
Metabolic rate, baseline insulin resistance, age, sex, and medication history also shape individual responses. People with severe insulin resistance often see more dramatic weight loss because semaglutide not only suppresses appetite but also improves how the body uses glucose. Conversely, someone with normal metabolic function may experience steadier, more gradual loss. PlexusDx personalizes your starting dose and adjustment strategy based on your genetic profile, reducing the trial-and-error phase many patients face.
Dose Adjustments and Progressive Weight Loss Results
Semaglutide therapy typically begins at a low dose (0.25 mg weekly) and increases every 4 weeks to allow your body to adapt and minimize side effects. Your dose may need to go up. Your price won't—PlexusDx charges a flat monthly rate regardless of dose level, meaning you pay the same price whether you're at the starting dose or the therapeutic dose. This transparent pricing structure removes the financial barrier to reaching the dose that works best for your body.
Many patients see initial weight loss at lower doses but then plateau; increasing the dose can trigger another round of weight loss. However, not everyone tolerates higher doses equally, and some people achieve optimal results at moderate doses while experiencing fewer side effects. The goal is finding your effective dose—the point where you lose weight consistently while maintaining quality of life. This process typically takes 12 to 16 weeks to complete, which is why most clinical trials report results at the 68-week mark rather than earlier.
Lifestyle, Adherence, and Long-Term Weight Loss Sustainability
Semaglutide reduces hunger and increases fullness, but it does not eliminate the need for conscious food choices or physical activity. Patients who combine medication with a protein-rich diet, consistent strength training, and adequate sleep lose more weight and maintain loss better than those who use medication alone. The drug creates a window of opportunity—when appetite is lower and satiety is stronger—that makes healthy decisions easier, but the decisions are still yours to make.
Research shows that stopping semaglutide typically leads to weight regain within months, because appetite hormones normalize and the original metabolic and genetic drivers of weight gain return. For sustainable results, many patients continue therapy long-term while maintaining the dietary and exercise habits they developed during active weight loss. PlexusDx supports this approach by offering ongoing care adjustments and access to the Precision Peptide Genetic Test, which can guide treatment modifications if your response changes over time or if you switch to a dual-compound therapy like GLP-Squared.
How Your Genetics Influence GLP-1 Response
Not everyone responds to GLP-1 medications the same way. Genetic variants — including GIPR rs1800437, GLP1R rs6923761, FTO rs9939609, and MC4R rs17782313 — influence how your body processes these medications, how much weight you lose, and how you tolerate side effects. PlexusDx maps 14 pathways, 49 peptides, and 150+ genetic insights to match each patient to the right medication, dose, and lifestyle protocol for their biology. The PlexusDx Precision Peptide Genetic Test ($99 add-on after your first month of treatment) gives your provider precise insight into your peptide genetic predispositions before the first prescription is written.
Access Personalized GLP-1 Care Through PlexusDx
PlexusDx offers six prescription GLP-1 protocols to all 50 states — no membership, no insurance required, async intake or live consult. The Semaglutide Injection starts at $149/mo. Medications are dispensed from licensed 503A compounding pharmacies following strict quality and safety standards. Add a Precision Peptide Genetic Test for $99 to personalize your protocol from day one.
Frequently Asked Questions
Can I expect to lose 30 pounds in three months on semaglutide?
Most people lose 5 to 10 pounds in the first month and 15 to 25 pounds by month three, though this varies widely based on genetics, starting weight, and dose tolerance. Rapid initial loss is usually water and glycogen; sustained fat loss continues more gradually. Individual timelines differ significantly, which is why PlexusDx recommends genetic testing to understand your personal response factors early in treatment.
Is the weight loss from semaglutide permanent?
Weight loss is maintained as long as you continue the medication and healthy habits; weight typically returns within months of stopping. Semaglutide is considered long-term therapy rather than a short-term intervention. Many patients find this model sustainable because ongoing treatment addresses the genetic and hormonal drivers that caused weight gain in the first place.
What's the difference between compounded semaglutide and brand-name Ozempic?
PlexusDx provides semaglutide from licensed 503A compounding pharmacies, which produce bioidentical medication at a significantly lower cost—starting at $149/month compared to $900+ for brand-name Ozempic. The active ingredient is the same; the difference is manufacturing and pricing. Compounded semaglutide is available in all 50 states, requires no insurance, and is HSA/FSA eligible.
Will I experience side effects that slow my weight loss?
Common side effects like nausea or reduced appetite (which is the mechanism, not a side effect) may discourage adequate eating in some patients. If side effects prevent you from eating enough protein or nutrients, they can slow loss or cause muscle loss. PlexusDx's personalized dosing strategy minimizes severe side effects, and slower dose escalation often leads to better tolerance and ultimately faster total weight loss over months.
How does the Precision Peptide Genetic Test predict my weight loss?
The test analyzes 14 metabolic and appetite-control pathways, including GLP1R and GIPR variants, plus FTO and MC4R genes that influence baseline weight regulation. These variants don't determine your result but explain biological factors that affect medication response, ideal dose, and whether dual-compound therapy (GLP-Squared) might work better than semaglutide alone. PlexusDx uses these insights to personalize your starting protocol, offered as a $99 add-on after your first month of treatment.
Related Reading
Pricing and availability current as of June 2026. Compounded GLP-1 medications are not FDA-approved drug products; they are prepared by licensed compounding pharmacies under federal compounding regulations. Compounded semaglutide and tirzepatide are not the same as Wegovy, Ozempic, Zepbound, or Mounjaro. This article is for informational purposes only and does not constitute medical advice. Consult a licensed healthcare provider before starting, stopping, or changing any medication.
Return to the PlexusDx Education Hub for more evidence-based resources on GLP-1 therapy, metabolic health, and personalized weight management.
Medical and Editorial Standards
Medical review process: This article was reviewed for medical accuracy, scientific clarity, evidence alignment, and appropriate discussion of genetics, medications, supplements, biomarkers, and health-related claims.
Sources and evidence: PlexusDx educational content is developed using peer-reviewed research, clinical literature, reputable medical references, and, where applicable, public health or regulatory guidance.
Commercial transparency: PlexusDx offers genetic testing, blood biomarker testing, personalized supplement recommendations, and related precision wellness services. Product mentions are intended to help readers understand available options and should not be interpreted as medical advice.
Important disclaimer: PlexusDx educational content is for informational purposes only and should not be used as a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making decisions about medications, supplements, genetic testing, lab testing, or health-related care.
Share:
What is GLP-1 Medication and How Can It Transform Your Weight Loss Journey?
What Are Natural GLP-1 Agonists?